Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro antimicrobial resistance properties of rifapentine and rifampicin are indistinguishable.

Microbiology spectrum - 7 Jul 2026

Barcelli Valeria, Shin Bora, Choo Barry Boon Liang, Dorett Sarah Leela, Bifani Pablo

Abstract excerpt

Tuberculosis (TB) is a major global health threat, with millions of new cases diagnosed annually. Rifampicin is a cornerstone drug in the current standard of care for TB treatment. Recently, rifapentine, an analog of rifampicin, has been considered as an alternative to rifampicin primarily due to its longer half-life and shorter 4-month TB treatment regimens. Despite some encouraging advantages in the clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Mycobacterium tuberculosis

Share to Rifampin

Source

Open in PubMed Open full text

Identifiers

PMID: 42148585
DOI: 10.1128/spectrum.00627-26
PMCID: PMC13339808

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro antimicrobial resistance properties of rifapentine and rifampicin are indistinguishable.PMID 42148585Read ↗

Rifampicin and rifabutin resistance in 1000 <i>Mycobacterium tuberculosis</i> clinical isolatesSemantic proximity Read ↗

Rifampin resistance-associated mutations in the RIF resistance-determining region (RRDR) of the rpoB gene of Mycobacterium tuberculosis clinical isolates in Shanghai, ChinaSemantic proximity Read ↗

Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex.Semantic proximity Read ↗

Drug susceptibility of the Mycobacterium genus: in vitro tests and clinical implications.Semantic proximity Read ↗

Exploring Mycobacterium Tuberculosis Resistance Patterns to Antibiotics: A BV-BRC StudySemantic proximity Read ↗

Direct detection from sputum for drug-resistant Mycobacterium tuberculosis using a CRISPR-Cas14a-based approachSemantic proximity Read ↗

[Drug resistance of clinical Mycobacterium tuberculosis isolates and molecular characteristics of rifampicin-resistant isolates from elderly pulmonary tuberculosis patients in Beijing, 2024].Semantic proximity Read ↗

Mechanisms of drug resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Phenotypic discordance in rifampicin resistance detection among Mycobacterium tuberculosis isolates from China: insights from whole-genome sequencing and a structured literature review.Semantic proximity Read ↗

A 10-Year Comparative Analysis Shows that Increasing Prevalence of Rifampin-Resistant Mycobacterium tuberculosis in China Is Associated with the Transmission of Strains Harboring Compensatory Mutations.Semantic proximity Read ↗

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Characteristic exploration of Mycobacterium tuberculosis isolated from patients with linezolid-treated multidrug-resistant tuberculosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.